Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11552204.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the efficacy of carbidopa L-dopa (Sinemet) in reducing left spatial neglect after stroke. Case series. Inpatient neurorehabilitation unit in a regional rehabilitation center. A convenience sample of 4 women with right brain strokes and left neglect. A trial of carbidopa L-dopa to treat left neglect, if indicated by selected subtests of the Behavioral Inattention Test (BIT). Baseline and posttreatment evaluation with the modified BIT and the FIM instrument. Three of 4 subjects had significant improvements in their modified BIT scores (8%, 12%, 27%, respectively) and their functional status on the FIM. With further study, carbidopa L-dopa may be shown to reduce unilateral spatial neglect and thereby improve rehabilitation outcomes.
Medical subject headings
- Carbidopa
- Dopamine Agents
- Levodopa
- Perceptual Disorders
- Stroke